Open Beta
TREN
MetriLume
TREN

US marketsKROS

SEC-sourced researchBeta

KROS

Keros Therapeutics, Inc.

Company comparison ↗

Data passport

CIK
0001664710
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 29, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 3,550,000.0000 USD; December 2025: 244,061,000.0000 USD244.1M USD0 USD0December 2024December 2025
KROS · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20243,550,000.0000Mar 4, 2026
December 2025244,061,000.0000Mar 4, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025244,061,000.000087,014,000.0000107,505,000.0000338,021,000.000034,889,000.0000Mar 4, 2026
December 20243,550,000.0000-187,353,000.0000-160,869,000.0000615,886,000.000044,333,000.0000Mar 4, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$244.06MDecember 2025Mar 4, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3.55MDecember 2024Mar 4, 202610-K
Net incomeNetIncomeLoss$87.01MDecember 2025Mar 4, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$107.51MDecember 2025Mar 4, 202610-K
Total assetsAssets$338.02MDecember 2025Mar 4, 202610-K
Total liabilitiesLiabilities$34.89MDecember 2025Mar 4, 202610-K

New filings

Explore methodology ↗